Lidocaína 2% Braun

Lidocaine, the active ingredient in Lidocaína 2% Braun, is a local anesthetic presented as a 2% solution for injection for epidural, intramuscular and intravenous use. It provides local anesthesia for minor surgical or diagnostic procedures and can be used for epidural analgesia and regional anesthesia.

GNH USA supplies Lidocaína 2% Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidocaine is a local anesthetic used to block nerve conduction in various clinical settings.

Minor surgical procedures: provides local anesthesia to facilitate pain‑free surgery. Diagnostic procedures: enables patient comfort during endoscopic or catheter‑based examinations. Epidural analgesia: delivers regional pain relief during labor or postoperative periods.

Adverse reactions to lidocaine may range from mild, transient events to rare but serious systemic effects.

Common Side Effects: - Transient burning or stinging at the injection site - Mild dizziness or light‑headedness - Nausea or vomiting - Tingling sensation in the lips or tongue

Serious or Rare Side Effects: - Systemic toxicity presenting as seizures, cardiac arrhythmias or hypotension - Allergic reactions such as urticaria, angioedema or anaphylaxis - Methemoglobinemia, a rare disorder affecting oxygen transport - Persistent neurologic deficits (very rare)

When using lidocaine, clinicians should observe several safety considerations to minimize risk.

Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. Cardiovascular status: avoid in patients with severe heart block or conduction disorders. Dosage limits: adhere to recommended maximum doses to prevent systemic toxicity. Concurrent CNS depressants: monitor for enhanced sedation or respiratory depression. Pregnancy and lactation: use only if the potential benefit justifies the potential risk to the fetus or infant. Store at ambient temperature: keep in the original container, protect from light and moisture.

Lidocaine may interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Class I antiarrhythmic agents (e.g., quinidine, procainamide): may increase cardiotoxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can raise plasma lidocaine concentrations. - Concurrent use of other local anesthetics: additive risk of systemic toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may potentiate bradycardia when combined with lidocaine. - General anesthetics such as propofol or volatile agents: may enhance central nervous system depression. - Loop diuretics (e.g., furosemide): may affect renal clearance of lidocaine.